Farrell C. Tyson, MD, FACS
Dr. Farrell C. Tyson practices among an elite group of eye physicians leading the research and development of new treatments for cataracts and eye diseases. A Johns Hopkins graduate with a degree in Biomedical Engineering, Dr. Tyson’s contributions continue to assist ophthalmologists worldwide in their ability to offer patients new advancements in vision technology. Dr. Tyson was one of the first in the world to utilize Intraoperative Wavefront Technology during cataract surgery, a technology that has revolutionized cataract surgery. Using sophisticated instruments, Dr. Tyson is able to capture real-time refractive measurements of the patient’s eye during surgery. This advanced approach will allow ophthalmologists to tailor intraoperative lenses immediately, reducing or even eliminating the need for postoperative surgery and/or postoperative eyeglasses.
Creating the World View on Eye Care
A clinical investigator for numerous studies reviewed by the FDA, Dr. Tyson has demonstrated and lectured on his research and experiences to fellow Ophthalmologists nationwide, and at such prestigious venues as the American Academy of Ophthalmology, the Turkish Glaucoma Congress in Izmir, the Russian National Ophthalmology Congress in Moscow, the Pan African American Congress of Ophthalmology in Dubai and the Congresses of the European Societies of Cataract and Refractive Surgeons (ESCRS) in England, Portugal, and Spain. He has also presented at the First International Symposium of Dhahran Eye Specialist Hospital in Saudi Arabia.
Ophthalmology Editorial Board
He served on the Editorial Boards of Cataract and Refractive Surgery Today, Review of Ophthalmology and Ophthalmology Management Magazine, for whom he has written a monthly column. He was also a contributing author to Advanced Ocular Care magazine and the textbook, Mastering Refractive IOLs, The Art and Science, published by SLACK, Inc. (Copyright 2008).
Dr. Tyson completed his undergraduate studies at Johns Hopkins University in Biomedical Engineering while participating in extensive research at the Wilmer Eye Institute. His many published research projects were in the evaluation of the Excimer laser which is now used extensively in LASIK surgery. He received his Doctor of Medicine from the University of South Florida College of Medicine. He completed his surgical internship at the Medical University of South Carolina, and his Ophthalmology residency at the Medical University of South Carolina at Charleston. He is board certified by the American Academy of Ophthalmologists, and a Fellow of the American College of Surgeons.
Dr. Tyson served on medical missions, providing ophthalmic aid to communities in Mexico, the Turks and Caicos Islands, Kenya and Honduras.
In 2006 Argus research was founded by Dr. Tyson, as a research branch of Cape Coral Eye Center (now Tyson Eye). Dr. Tyson has been involved in more than 60 clinical trials. Some of these clinical trials include treatments for dry eyes, anti-inflammatory medications, cataract surgery and glaucoma. Clinical research is essential in the development of new techniques, medications, and devices to maintain or improve the vision of the patients we serve.